Drawing for SARAPIN

USPTO serial 90845127

SARAPIN

Reviewed by CopyMark Law Group

Status 731Notice of Allowance
Filing date
Status date
Registration date
Examiner
FROMM, MARTHA L
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 731: Status 731 means the second six-month extension to file a Statement of Use was granted. File a Statement of Use or the next extension before the deadline expires.

Need help with SARAPIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mary Margaret L. O'Donnell

Mary Margaret L. O'Donnell Blue Filament Law PLLC772 E. Maple RoadBirmingham, MI 48009United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in treating locomotor dysfunctions, musculoskeletal problems, arthritis pain, joint pain, acute and chronic pain disorders, asthma, tumors, wounds, skin disorders, allergies, infectious diseases, bacterial and viral infections in humans and animals; pharmaceutical preparations, namely, preparations of phytotherapy, antivirals and antibacterials; pharmaceutical preparations being natural remedies for use in the treatment of locomotor dysfunctions, musculoskeletal problems, arthritis pain, joint pain, acute and chronic pain disorders, asthma, tumors, wounds, skin disorders, allergies, infectious diseases, bacterial and viral infections in humans and animals; medical and veterinary preparations for human and animal health purposes, namely, natural herbal and bacteriological preparations for medical or veterinary purposes, diagnostic preparations for medical or veterinary purposes; medical and veterinary preparations for human and animal health purposes, namely, natural remedy preparations for the treatment of locomotor dysfunctions, musculoskeletal problems, arthritis pain, joint pain, acute and chronic pain disorders, asthma, tumors, wounds, skin disorders, allergies, infectious diseases, bacterial and viral infections in humans and animals; medicated cosmetics; sanitary preparations for medical use; sanitary preparations for medical purposes; dietary supplements for humans and animals; dietetic beverages adapted for veterinary use; dietetic foods adapted for veterinary use; dietetic beverages adapted for medical use; dietetic food adapted for veterinary use; dietetic foods adapted for medical use; dietetic foods and beverages adapted for medical use; dietary supplements; dietary food supplements; dietary supplemental drinks; dietary supplements for animals; dietary supplements for humans; dietary supplements with a cosmetic effect; wound dressings; surgical dressings; bandages for dressings; self-adhesive dressings; burn dressings; dressing for surgery; medical and surgical plasters; plasters for medical purposesACTIVE
010Medical devices, namely, medical guidewires and parts and fittings therefor; medical devices for measuring wounds and for closing wounds; medical cutting devices for use in surgery, said goods being for medical, dental or veterinary use; medical apparatus and instruments, namely, medical guidewires and parts and fittings therefor; medical devices for measuring and closing wounds, said goods being for use in surgery; medical devices, namely, imaging apparatus in the nature of X-ray apparatus, ultrasound apparatus, apparatus for shockwave therapy, MRI apparatus, computed tomography (CT)scanning apparatus, orthopaedic apparatus and instruments, and surgical apparatus and instruments for medical, dental or veterinary use; medical devices for monitoring vital signs, blood oxygen saturation, blood gas concentrations and respiratory events, for human and animal health purposes; surgical devices and instruments for human and animal health purposes; surgical apparatus and instruments for human and animal health purposes; surgical apparatus and instruments for veterinary use; surgical apparatus and instruments for medical, dental or veterinary use; veterinary apparatus for animal health purposes, namely, medical imagery apparatus for veterinary use; surgical apparatus and instruments for medical, dental, or veterinary use; orthopaedic instruments for diagnostic and therapeutic use and for use in orthopaedic treatment and surgery, for human and animal health purposes; orthopaedic apparatus for diagnostic and therapeutic use and for use in orthopaedic surgery for human and animal health purposes; orthopaedic articles for human and animal health purposes, namely, orthopaedic joint implants made of non-living natural or artificial materials; orthopaedic articles for human and animal health purposes, namely, external and injectable devices in the nature of orthopedic devices for injecting drugs into joint spaces and orthopedic joint implants of non-living naturalor artificial materials for analgesic purposes and use in treating locomotor dysfunctions; orthopaedic articles for human and animal health purposes, namely, orthopaedic insoles, soles and footwear; orthopaedic articles for human and animal health purposes, namely, orthopaedic bandages, knee bandages, splints, ankle, wrist, knee and elbow supports, support bandages and braces; orthopaedic articles for human and animal health purposes, namely, hip prostheses and walkers; orthopaedic bandagesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 5, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 5, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 5, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 5, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 4, 2026EX2GSOU EXTENSION 2 GRANTED
May 4, 2026EXT2SOU EXTENSION 2 FILED
May 4, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 12, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 11, 2025EX1GSOU EXTENSION 1 GRANTED
Sep 11, 2025EXT1SOU EXTENSION 1 FILED
Sep 11, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 10, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 15, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 15, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 9, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 21, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 21, 2025XAECEXAMINER'S AMENDMENT ENTERED
Mar 21, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 21, 2025GNEAEXAMINERS AMENDMENT E-MAILED
Mar 21, 2025CNEAEXAMINERS AMENDMENT -WRITTEN
Jun 6, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 6, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 24, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 24, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 23, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 23, 2024NREVNOTICE OF REVIVAL - E-MAILED
May 23, 2024PETGPETITION TO REVIVE-GRANTED
May 23, 2024PROATEAS PETITION TO REVIVE RECEIVED
Feb 20, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 20, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 20, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 1, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 7, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 4, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 4, 2023GNSLLETTER OF SUSPENSION E-MAILED
Jan 4, 2023CNSLSUSPENSION LETTER WRITTEN
Dec 14, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 14, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 2022ALIEASSIGNED TO LIE
Oct 21, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 25, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 25, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 25, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 19, 2022DOCKASSIGNED TO EXAMINER
Sep 23, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 27, 2021NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance